Scott Gottlieb: GLP-1 drugs are a profound medical advance on par with statins

Dr. Scott Gottlieb, former FDA commissioner, joins ‘Power Lunch’ to discuss how big the GLP-1 drugs are likely to be, what could make the drugs hard for insurance not to pay for, and much more.